Management of the acute respiratory distress syndrome

Chest Surgery Clinics of North America

Volumn 12, Issue 2, 2002, Pages 325-354

  Conrad, Steven A ^a   Bidani, Akhil ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIOXIDANT; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; CYTOKINE; ENDOTHELIN; ENDOTOXIN ANTIBODY; IBUPROFEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; KETOCONAZOLE; LIPOPROSTAGLANDIN E1; METHYLPREDNISOLONE; NARCOTIC AGENT; NEUROMUSCULAR BLOCKING AGENT; NITRIC OXIDE; PROPOFOL; PROSTACYCLIN; PROSTAGLANDIN E1; SURFACTANT; TUMOR NECROSIS FACTOR ANTIBODY; VECURONIUM; VASODILATOR AGENT;

ARTIFICIAL VENTILATION; GAS EXCHANGE; HUMAN; HYPERCAPNIA; HYPOXIA; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; LIQUID VENTILATION; LUNG INJURY; LUNG MECHANICS; MEDIATOR RELEASE; MULTIPLE ORGAN FAILURE; NEUROMUSCULAR BLOCKING; PATIENT POSITIONING; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; REVIEW; SEDATION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIDAL VOLUME; VENTILATOR; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; BODY POSTURE; BREATHING MECHANICS; CLINICAL TRIAL; ELECTROLYTE BALANCE; EXTRACORPOREAL OXYGENATION; LUNG GAS EXCHANGE; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMAL; CLINICAL TRIALS; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMAN; NEUROMUSCULAR BLOCKING AGENTS; NITRIC OXIDE; POSITIVE-PRESSURE RESPIRATION; PRONE POSITION; PULMONARY GAS EXCHANGE; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY MECHANICS; SUPPORT, U.S. GOV'T, P.H.S.; VASODILATOR AGENTS; WATER-ELECTROLYTE BALANCE; ANIMALS; HUMANS;

EID: 0035992094     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3359(02)00012-1     Document Type: Review

References (157)

1. Acute respiratory distress in adults
2. Mechanisms of lung injury
3. Introduction and definition
4. Adult respiratory distress syndrome (a perspective based on 18 years' personal experience)
5. The acute respiratory distress syndrome
6. Lung mechanics in the adult respiratory distress syndrome: Recent conceptual advances and implications for management
7. A simple automated method for measuring pressure-volume curves during mechanical ventilation
8. Volume-pressure curve of the respiratory system predicts effects of PEEP in ARDS: "Occlusion" versus "constant flow" technique
9. Effects of ventilation in ventral decubitus position on respiratory mechanics in adult respiratory distress syndrome
10. Pressure-volume curves in acute respiratory failure: Automated low flow inflation versus occlusion
11. Recruitment and derecruitment during acute respiratory failure: A clinical study
12. Pressure-volume curves and compliance in acute lung injury: Evidence of recruitment above the lower inflection point
13. Closing pressure rather than opening pressure determines optimal positive end-expiratory pressure and avoids overdistention
14. Best compliance during a decremental but not incremental positive end-expiratory pressure trial is related to open-lung positive end-expiratory pressure: A mathematical model of acute respiratory distress syndrome lungs
15. Effects of pressure-controlled with different I:E ratios versus volume-controlled ventilation on respiratory mechanics gas exchange and hemodynamics in patients with adult respiratory distress syndrome
16. Randomized prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure
17. Prospective randomized trial comparing pressure-controlled ventilation and volume-controlled ventilation in ARDS
18. Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome
19. Impaired oxygenation in surgical patients during general anesthesia with controlled ventilation: A concept of atelectasis
20. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: Protection by positive end-expiratory pressure
21. Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats
22. High inflation pressure pulmonary edema: Respective effects of high airway pressure high tidal volume and positive end-expiratory pressure
23. Chest wall restriction limits high airway pressure-induced lung injury in young rabbits
24. Extreme hypoventilation reduces ventilator-induced lung injury during ventilation with low positive end-expiratory pressure in saline-lavaged rabbits
25. Tidal ventilation at low airway pressures can augment lung injury
26. Effects of decreased respiratory frequency on ventilator-induced lung injury
27. High tidal volume ventilation produces increased lung water in oleic acid-injured rabbit lungs
28. Adverse effects of large tidal volume and low PEEP in canine acid aspiration
29. High lung volume increases stress failure in pulmonary capillaries
30. Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study
31. Lung edema caused by high peak inspiratory pressures in dogs: Role of increased microvascular filtration pressure and permeability
32. Barotrauma and microvascular injury in lungs of nonadult rabbits: Effect of ventilation pattern
33. Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures
34. Acute lung injury from mechanical ventilation at moderately high airway pressures
35. Mechanical ventilation-induced pulmonary edema: Interaction with previous lung alterations
36. Effect of granulocyte depletion in a ventilated surfactant-depleted lung
37. Lung injury caused by mechanical ventilation
38. Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome
39. Activation of human macrophages by mechanical ventilation in vitro
40. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial
41. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model
42. Mechanotransduction across the cell surface and through the cytoskeleton
43. Ventilator-induced injury: From barotrauma to biotrauma
44. Invited review: Mechanisms of ventilator-induced lung injury: A perspective
45. Ventilator-induced lung injury: Lessons from experimental studies
46. Pressure-volume curve of total respiratory system in acute respiratory failure: Computed tomographic scan study
47. Histologic aspects of pulmonary barotrauma in critically ill patients with acute respiratory failure
48. Permissive hypercapnia in acute respiratory failure
49. The ARDS lung: New insights from computed tomography
50. Target blood gases during ARDS ventilatory management
51. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome
52. Low mortality rate in adult respiratory distress syndrome using low-volume pressure-limited ventilation with permissive hypercapnia: A prospective study
53. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome: Pressure- and Volume-Limited Ventilation Strategy Group
54. Protective ventilation for patients with acute respiratory distress syndrome
55. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
56. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome
57. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome: A prospective randomized study on mechanical ventilation
58. Resuscitation from severe acute hypercapnia: Determinants of tolerance and survival
59. 3 in experimental lactic acidosis in dogs
60. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: A prospective controlled clinical study
61. Combined ventilator and bicarbonate strategy in the management of status asthmaticus
62. Permissive hypercapnia
63. Acid-base regulation: Cellular and whole body
64. Use of extreme position changes in acute respiratory failure
65. Improved oxygenation in patients with acute respiratory failure: The prone position
66. Prone position in mechanically ventilated patients with severe acute respiratory failure
67. The effects of early and repeated prone positioning in pediatric patients with acute lung injury
68. The effects of long-term prone positioning in patients with trauma-induced adult respiratory distress syndrome
69. 4A randomized trial of prolonged prone positioning in children with acute respiratory failure
70. The prone position in ARDS patients: A clinical study
71. Dramatic effect on oxygenation in patients with severe acute lung insufficiency treated in the prone position
72. Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury
73. Prone positioning and low-volume pressure-limited ventilation improve survival in patients with severe ARDS
74. Relationships between lung computed tomographic density gas exchange and PEEP in acute respiratory failure
75. Body position changes redistribute lung computed-tomographic density in patients with acute respiratory failure
76. Lung structure and function in different stages of severe adult respiratory distress syndrome
77. The prone position improves arterial oxygenation and reduces shunt in oleic-acid-induced acute lung injury
78. Mechanism by which the prone position improves oxygenation in acute lung injury
79. Vertical gradient of regional lung inflation in adult respiratory distress syndrome
80. Effects of anesthesia and paralysis on diaphragmatic mechanics in man
81. Abdominal distension alters regional pleural pressures and chest wall mechanics in pigs in vivo
82. Effect of heart weight on distribution of lung surface pressures in vertical dogs
83. Influence of the heart on the vertical gradient of transpulmonary pressure in dogs
84. Effect of prone positioning on the survival of patients with acute respiratory failure
85. Is a short trial of prone positioning sufficient to predict the improvement in oxygenation in patients with acute respiratory distress syndrome?
86. Administration of therapeutic aerosols to mechanically ventilated patients
87. Inhaled nitric oxide therapy
88. Inhaled nitric oxide in acute respiratory failure
89. Nitric oxide and the lung
90. Inhaled nitric oxide lowers pulmonary capillary pressure and changes longitudinal distribution of pulmonary vascular resistance in patients with acute lung injury
91. Efficacy of inhaled nitric oxide in patients with severe ARDS
92. Nitric oxide (NO) in expired air at rest and during exercise
93. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx
94. Inhaled nitric oxide in acute respiratory failure: Dose-response curves
95. Inhaled nitric oxide for the adult respiratory distress syndrome
96. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome
97. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial
98. Nitric oxide in adult lung disease
99. Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome
100. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure
101. Inhaled nitric oxide versus conventional therapy: Effect on oxygenation in ARDS
102. Development of a time-cycled volume-controlled pressure-limited respirator and lung mechanics system for total liquid ventilation
103. Recent innovations in total liquid ventilation system and component design
104. Total liquid ventilation with perfluorocarbons increases pulmonary end-expiratory volume and compliance in the setting of lung atelectasis
105. Liquid ventilation improves pulmonary function gas exchange and lung injury in a model of respiratory failure
106. Improvement of gas exchange pulmonary function and lung injury with partial liquid ventilation: A study model in a setting of severe respiratory failure
107. Efficacy of perfluorocarbon partial liquid ventilation in a large animal model of acute respiratory failure
108. Intratracheal perfluorocarbon administration as an aid in the ventilatory management of respiratory distress syndrome
109. Partial liquid in adult patients with ARDS: A multicenter phase I-II trial
110. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome
111. Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients
112. Liquid ventilation
113. Partial liquid ventilation (PLV) in acute respiratory failure
114. Liquid ventilation
115. Fluid balance during pulmonary edema: Is fluid gain a marker or a cause of poor outcome?
116. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization
117. Right ventricular volumetric measurements: New tricks for an old dog
118. Volume therapy in the intensive care patient: We are still confused but
119. Persistent paralysis in critically ill patients after long-term administration of vecuronium
120. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants
121. Myopathy in severe asthma
122. Prolonged weakness after long-term infusion of vecuronium bromide
123. High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation minimal sedation and pressure supported ventilation
124. Selection criteria for use of ECLS in adults
125. Veno-arterial-venous bypass for combined cardiorespiratory failure
126. Supportive pharmacotherapy for patients with acute respiratory distress syndrome
127. Multiple systems organ failure: Epidemiology and prognosis
128. Whole body inflammation in trauma patients: An autopsy study
129. Immunological therapy of sepsis: Experimental therapies
130. Immunological therapy in sepsis: Currently available
131. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
132. Efect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis
133. High-dose corticosteroids in patients with the adult respiratory distress syndrome
134. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
135. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective randomized double-blind single-center study
136. Effects of the combination of hydrocortisone (HC)-fludro-cortisone (FC) on mortality in septic shock
137. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: Patterns of response and predictors of outcome
138. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial
139. Efficacy and safety of recombinant human activated protein C for severe sepsis
140. A second large controlled clinical study of E5 a monoclonal antibody to endotoxin: Results of a prospective multicenter randomized controlled trial
141. Treatment of septic shock with human monoclonal antibody HA-1A: A randomized double-blind placebo-controlled trial
142. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
143. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized double-blind placebo-controlled trial
144. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III randomized double-blind placebo-controlled multicenter trial
145. 1 in patients with the adult respiratory distress syndrome
146. 1 (TLC C-53) in acute respiratory distress syndrome: A controlled randomized double-blind multicenter clinical trial
147. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome a randomized controlled trial
148. The effects of ibuprofen on the physiology and survival of patients with sepsis
149. Effect of ibuprofen in patients with severe sepsis: A randomized double-blind multicenter study
150. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome
151. 2 inhibitor: A new class of anti-inflammatory drugs
152. The potential role of platelet-activating factor (PAF) in shock sepsis and adult respiratory distress syndrome (ARDS)
153. Platelet-activating factor (PAF) in experimental and clinical sepsis
154. Neutrophil elastase inhibitor ONO-5046 modulates acid-induced lung and systemic injury in rabbits
155. Effects of neutrophil elastase inhibitor (ONO-5046) on lung injury after intestinal ischemia-reperfusion
156. Clinical trials in sepsis and septic shock